I recently came across a 'Mayo Clinic Proceeding'
that may be of interest to those who experience Neuropathic Pain.... and that's a lot of us.
Apparently, the Neuropathic Pain Special Interest Group of the 'International Association for the Study of Pain' sponsored the development of some 'evidence-based' guidelines.You may read it by googling:[/u]
Mayo Clin Proc. 2010 March; 85(3_suppl): S3-S14
First-line treatment options:
Second-line treatment options:
- Tricyclic antidepressants,
- dual reuptake inhibitors of serotonin and norepinephrine,
- calcium channel α2-δ ligands (ie, gabapentin and pregabalin), and
- topical lidocaine.
- Opioid analgesics, and
So it appears that there are more medicinal tools available for doctors to use. Some of these first line treatments are not often mentioned by members as being prescribed to them.
Something to think about! Possibly an opportunity for improved pain management by discussing this tactfully with our doctors?(For completeness, I've included these definitions.
Neuropathic Pain has recently been redefined as “pain arising as a direct consequence of a lesion or disease affecting the somatosensory system.”
"The somatosensory system is a diverse sensory system comprising the receptors and processing centres to produce the sensory modalities such as touch, temperature, proprioception (body position), and nociception (pain)." "Sensory receptors cover the skin and epithelia, skeletal muscles, bones and joints, internal organs, and the cardiovascular system.")